Skip to main content
. Author manuscript; available in PMC: 2020 Jul 3.
Published in final edited form as: Am J Nephrol. 2019 Jul 3;50(2):144–151. doi: 10.1159/000501510

Figure 1B.

Figure 1B.

Observed versus predicted time available in CKD stage 5 based on medication and laboratory data associated with progression of CKD.

Reference group used in tests for statistically significant differences for all characteristics is the first row for each subdivision (e.g. no diuretic, no ACE/ARB).